NCT07178080Enrolling by invitation
Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound
Comparative Analysis of PIUR Imaging Technology for Volume Reduction Rate Measurement in Thyroid Nodule Ablations
Source: ClinicalTrials.gov · Last updated 17 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
After thyroid ablation procedure, the volume of the thyroid nodule (s) needs to be measured to see how well the procedure worked. Currently, these volumes are measured using traditional 2D ultrasound imaging. However, this approach comes with limitations because of the information 2D images cannot gather and because of differences in these measurements between different doctors. A new ultrasound technology called PIUR 3D imaging offers a novel alternative approach. The system uses advanced technology to create 3D images and can generate automated volume estimates. The PIUR imaging system, PIUR tUS Infinity, has been cleared by the Food and Drug Administration (FDA) to aid in treatment decisions when used alongside traditional 2D ultrasound imaging. The purpose of this study is to test how effective and consistent the PIUR imaging technology is compared to standard 2D ultrasound in measuring thyroid nodule volume.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 7 Sept 2025
- Start date
- 8 Sept 2025
- Primary completion date
- 8 Sept 2027
- Lead sponsor
- Sarasota Memorial Health Care System
- NCT number
- NCT07178080
What you commit to
- Study type: Interventional
- Planned participants: 75
- From 8 Sept 2025 to the primary completion date, 8 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Under 22 years of age
Other
- Unable to undergo follow-up imaging
- Pregnancy
- Patients may be excluded at the physician's discretion based on their clinical judgement and/or if the health or safety of the patient may be potentially impacted by participating in this study.
Who the study is looking for
- 22 years old or older
- Patient of Dr. Ralph Tufano's office
- Undergoing thyroid nodule ablation
- The patient or their LAR must be willing and able to provide informed consent
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sarasota Memorial Health Care System Coordinator of this site? Confirm its status | Sarasota | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.